Clinical Trials
17 trialsNCT01107522 2025-09-09
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With TemodarĀ® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With TemodarĀ® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Tactical Therapeutics, Inc.
Phase 1 Unknown
NCT05929456 2023-07-03
MIRROR
University Medical Center Groningen
Phase 1 Unknown
NCT01672463 2023-03-29
OKN-007
Oblato, Inc.
Phase 1 Unknown
NCT05540873 2023-01-06
A Clinical Study of IL13RĪ±2 Targeted CAR-T in Patients With Malignant Glioma (MAGIC-I)
CellabMED
Phase 1 Unknown
NCT05063682 2021-10-01
CARTREMENDOUS
Chembrain LTD
Phase 1 Unknown
NCT04943718 2021-06-29
Personalized Vaccine for Patients With Recurrent Malignant Glioma
Xuanwu Hospital, Beijing
Phase 1 Unknown
NCT03423992 2021-06-15
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
Xuanwu Hospital, Beijing
Phase 1 Unknown
NCT04906473 2021-05-28
Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors
Kunming Pharmaceuticals, Inc.
Phase 1 Unknown
NCT03463733 2020-10-08
HUTMZ
Amsterdam UMC, location VUmc
Phase 1 Unknown
NCT04550663 2020-09-23
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1 Unknown
NCT03392545 2019-07-11
InSituVac1
Beijing Tiantan Hospital
Phase 1 Unknown
NCT02345824 2018-06-07
Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma
University of Virginia
Phase 1 Unknown
NCT02149459 2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1 Unknown
NCT00083096 2015-02-10
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Unknown
NCT00516607 2015-02-10
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Unknown
NCT02331693 2015-01-06
CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR
RenJi Hospital
Phase 1 Unknown
NCT00591058 2009-07-17
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
TransMolecular
Phase 1 Unknown